Manuscripts from the laboratory and PI are presented by year of publication.
2024
- Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma. Gastroenterology.
2023
- Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1. Science Immunology.
2021
- Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. Cancers.
- Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patients. JCI Insight.
- A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma. Molecular Cancer Therapeutics.
2020
- Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle. Seminars in Cancer Biology.